AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,097 Cr | ₹1,163 Cr | ₹1,809 Cr | ₹867 Cr | ₹903 Cr |
What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹1,097 Cr |
| Mar2025 | ₹1,163 Cr |
| Mar2024 | ₹1,809 Cr |
| Mar2023 | ₹867 Cr |
| Mar2022 | ₹903 Cr |
How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,097 Cr | -5.68 | |
| Mar2025 | ₹1,163 Cr | -35.72 | |
| Mar2024 | ₹1,809 Cr | 108.67 | |
| Mar2023 | ₹867 Cr | -4.01 | |
| Mar2022 | ₹903 Cr | - | |
Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹98,968.8 Cr | -0.9% | 7.3% | 52.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -0.9% |
7.3% |
52.9% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses